Alamar Biosciences Inc. (ALMR) Financials
All currency values in $ millions unless otherwise noted
| Income Statement | DEC 2025 | DEC 2024 |
|---|---|---|
| Revenues | ||
| Revenue | $74 | $25 |
| Cost of Revenue | $33 | $17 |
| Gross Profit | $42 | $9 |
| Total Operating Expenses | $73 | $58 |
| Operating Income | -$31 | -$50 |
| Non-Operating | ||
| Net Interest Expense | -$0 | -$2 |
| Income Tax Expense | $1 | $0 |
| Net Income | ||
| Net Income | -$30 | -$47 |
| Per Share Data | ||
| Revenue Per Share | $1.12 | $0.38 |
| EPS (Basic) | -$0.45 | -$0.71 |
| EPS (Diluted) | -$0.45 | -$0.71 |
| Shares Outstanding | 66.5M | 66.5M |
Related stocks: Medical Devices
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.